Home » Biotin 633 Biotium

Biotin 633 Biotium

MitoView 633
70055 20X50UG
EUR 226
Description: Minimum order quantity: 1 unit of 20X50UG

Biotium Laboratories manufactures the biotin 633 biotium reagents distributed by Genprice. The Biotin 633 Biotium reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Biotium. Other Biotin products are available in stock. Specificity: Biotin Category: 633 Group: Biotium

D(+)-Biotin
1G
EUR 94
Description: Minimum order quantity: 1 unit of 1G

Aminooxy-biotin
5MG
EUR 255
Description: Minimum order quantity: 1 unit of 5MG

Biotin azide
1MG
EUR 125
Description: Minimum order quantity: 1 unit of 1MG

Biotin alkyne
1MG
EUR 125
Description: Minimum order quantity: 1 unit of 1MG

Biotin BCN
1MG
EUR 406
Description: Minimum order quantity: 1 unit of 1MG

Biotin methyltetrazine
1mg
EUR 355
Description: Minimum order quantity: 1 unit of 1mg

Biotin TCO
1mg
EUR 355
Description: Minimum order quantity: 1 unit of 1mg

Biotium information

Anti-human CD32 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC01450-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD32 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD90 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC01818-Biotin 100µg
EUR 268
Description: Mouse Monoclonal human CD90 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD7 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC01974-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD7 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD235a Monoclonal Antibody Biotin Conjugated, Flow Validated
FC02184-Biotin 100µg
EUR 245
Description: Mouse Monoclonal human CD235a Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD8 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC02236-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD8 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-Human VEGI Monoclonal Antibody Biotin Conjugated, Flow Validated
FC02402-Biotin Various Sizes
EUR 497
Description: Mouse Monoclonal Human VEGI Antibody Biotin Conjugated, Flow Validated. Validated in WB and tested in Human.

Anti-human CD3 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC02675-Biotin 100µg
EUR 152
Description: Mouse Monoclonal human CD3 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD20 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC03780-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD20 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD10 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC04065-Biotin 100µg
EUR 189
Description: Mouse Monoclonal human CD10 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD57 Monoclonal Antibody Biotin Conjugated, Flow Validated
FC09548-Biotin 100µg
EUR 245
Description: Mouse Monoclonal human CD57 Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human HLA-DR Monoclonal Antibody Biotin Conjugated, Flow Validated
FC00568-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human HLA-DR Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

Anti-human CD55/Daf Monoclonal Antibody Biotin Conjugated, Flow Validated
FC00910-Biotin 100µg
EUR 233
Description: Mouse Monoclonal human CD55/Daf Antibody Biotin Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human.

PD1 Antibody [7H6] (biotin)
RF16003-biotin-002mg 0.02 mg
EUR 191.42
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins.

PD1 Antibody [7H6] (biotin)
RF16003-biotin-01mg 0.1 mg
EUR 495.22
Description: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD-1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. PD-1 is thus one of a growing number of immune checkpoint proteins.

PDL1 Antibody [8E12] (biotin)
RF16032-biotin-002mg 0.02 mg
EUR 191.42
Description: PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC) (1). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC (2). PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells (3). This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. PD-L1 also functions as an immune checkpoint protein, and multiple anti-PD-L1 antibodies are currently in phase II and III clinical trials, with one antibody already approved for the treatment of cancer (4).

PDL1 Antibody [8E12] (biotin)
RF16032-biotin-01mg 0.1 mg
EUR 495.22
Description: PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC) (1). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC (2). PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells (3). This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. PD-L1 also functions as an immune checkpoint protein, and multiple anti-PD-L1 antibodies are currently in phase II and III clinical trials, with one antibody already approved for the treatment of cancer (4).

TIGIT Antibody [10B1] (biotin)
RF16058-biotin-002mg 0.02 mg
EUR 191.42
Description: TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity; this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2).